Muestra las diferencias entre dos versiones de la página.
Ambos lados, revisión anterior Revisión previa | |||
es:tema:corona:hidroxicloroquina [2020/06/10 23:00] geronimo [Estudios existentes] |
es:tema:corona:hidroxicloroquina [2020/06/10 23:03] (actual) geronimo [Referencias] |
||
---|---|---|---|
Línea 16: | Línea 16: | ||
====== Referencias ====== | ====== Referencias ====== | ||
* Geleris, Joshua, Yifei Sun, Jonathan Platt, Jason Zucker, Matthew Baldwin, George Hripcsak, Angelena Labella, et al. « [[ https://doi.org/10.1056/NEJMoa2012410|Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19]] ». New England Journal of Medicine | * Geleris, Joshua, Yifei Sun, Jonathan Platt, Jason Zucker, Matthew Baldwin, George Hripcsak, Angelena Labella, et al. « [[ https://doi.org/10.1056/NEJMoa2012410|Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19]] ». New England Journal of Medicine | ||
+ | * Horby & Landray. " [[ https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19|No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19]] ". | ||
* Rosenberg, Eli S., Elizabeth M. Dufort, Tomoko Udo, Larissa A. Wilberschied, Jessica Kumar, James Tesoriero, Patti Weinberg, et al. « [[ https://doi.org/10.1001/jama.2020.8630|Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State]] ». JAMA, 11 mai 2020. | * Rosenberg, Eli S., Elizabeth M. Dufort, Tomoko Udo, Larissa A. Wilberschied, Jessica Kumar, James Tesoriero, Patti Weinberg, et al. « [[ https://doi.org/10.1001/jama.2020.8630|Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State]] ». JAMA, 11 mai 2020. | ||